BridgeMD
New treatment option for Skin Massage
Official title Exploring the Cutaneous Immune Response to Skin Massage in Early Life
ClinicalTrials.gov ID: NCT07228728
What this study is testing
- What it's testing
- This project aims to study whether regular skin massage in babies induces cutaneous inflammation and whether this inflammatory response is amplified in those receiving daily (vs bi-weekly or no) skin massage over an 8 week period. Specifically, it aims to: 1.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 0 to 6. Healthy volunteers may be eligible.
You may be able to join if
- Healthy babies born at term up to 6 months old
- Ability of parents/guardians/caregivers to provide written informed consent for study participation
- Willingness of parents/guardians/caregivers to comply with all study requirements.
You likely can't join if
- Parents/guardians/caregivers unable to give informed consent.
- Personal history of inflammatory skin disease (in particular atopic dermatitis)
- Active involvement in another treatment research study
The study team makes the final eligibility decision.
Where it's taking place
- London, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0 months to 6 months. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include London, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.